Ag In Motion Discovery Plus A Virtual Success

Jul 28, 2020

Ag in Motion's virtual Discovery Plus event wrapped up on Saturday.

Organizers are pleased with how it all turned out. Show Director Rob O'Connor says about 9000 people took part in the online sessions.

"I thought the variety of the program was a good thing for us because we had ranchers and farmers from across the Prairies participating in the different sessions."

He notes the online platform worked really well.

"When it was all said and done I would properly term this event more as a giant convention because of the number of sessions and presentations that we had. We saw a lot of people logging on to watch presentations for half an hour and then go and come back in a few hours to watch other presentations."

He says it was the first time in North America that a farm show of this magnitude went digital.

O'Conner notes they also had organizers from shows in the US, Germany, India and Australia go online to check out the event to see how it worked.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.